Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37


[Immunotherapy for cancer: from medical breakthrough to application in daily practice].

Dekker NRP, Stigt JA, Visser O, Netters FJS, Koornstra RHT, de Groot JWB.

Ned Tijdschr Geneeskd. 2019 May 31;163. pii: D3782. Dutch.


Systematic and combined endosonographic staging of lung cancer (SCORE study).

Crombag LMM, Dooms C, Stigt JA, Tournoy KG, Schuurbiers OCJ, Ninaber MK, Buikhuisen WA, Hashemi SMS, Bonta PI, Korevaar DA, Annema JT.

Eur Respir J. 2019 Feb 7;53(2). pii: 1800800. doi: 10.1183/13993003.00800-2018. Print 2019 Feb.


Workplace mentoring of residents in generic competencies by an independent coach.

Stigt JA, Koele JH, Brand PLP, Jaarsma DAC, Slootweg IA.

Perspect Med Educ. 2018 Oct;7(5):337-341. doi: 10.1007/s40037-018-0452-7.


Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.

De Ruysscher D, Dingemans AC, Praag J, Belderbos J, Tissing-Tan C, Herder J, Haitjema T, Ubbels F, Lagerwaard F, El Sharouni SY, Stigt JA, Smit E, van Tinteren H, van der Noort V, Groen HJM.

J Clin Oncol. 2018 Aug 10;36(23):2366-2377. doi: 10.1200/JCO.2017.77.5817. Epub 2018 May 22.


A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).

Boshuizen RC, Vd Noort V, Burgers JA, Herder GJM, Hashemi SMS, Hiltermann TJN, Kunst PW, Stigt JA, van den Heuvel MM.

Lung Cancer. 2017 Jun;108:9-14. doi: 10.1016/j.lungcan.2017.01.019. Epub 2017 Feb 16.


EUS-B-FNA vs conventional EUS-FNA for left adrenal gland analysis in lung cancer patients.

Crombag LMMJ, Szlubowski A, Stigt JA, Schuurbiers O, Korevaar DA, Bonta PI, Annema JT.

Lung Cancer. 2017 Jun;108:38-44. doi: 10.1016/j.lungcan.2017.02.011. Epub 2017 Feb 20.


Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

Slotman BJ, Faivre-Finn C, van Tinteren H, Keijser A, Praag J, Knegjens J, Hatton M, van Dam I, van der Leest A, Reymen B, Stigt J, Haslett K, Tripathi D, Smit EF, Senan S.

Lung Cancer. 2017 Jun;108:150-153. doi: 10.1016/j.lungcan.2017.03.007. Epub 2017 Mar 21.


Spondylodiskitis after Dilatation of Esophageal Radiation Stenosis: A Suspect for Metastasis.

Stigt JA, Vossenkaul R, de Vos Tot Nederveen Cappel WH.

J Thorac Oncol. 2017 Jun;12(6):1021-1022. doi: 10.1016/j.jtho.2017.03.016. Epub 2017 Mar 27. No abstract available.


Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Hendriks LE, Brouns AJ, Amini M, Uyterlinde W, Wijsman R, Bussink J, Biesma B, Oei SB, Stigt JA, Bootsma GP, Belderbos JS, De Ruysscher DK, Van den Heuvel MM, Dingemans AC.

Lung Cancer. 2016 Nov;101:68-75. doi: 10.1016/j.lungcan.2016.09.008. Epub 2016 Sep 9.


Current generation time-of-flight (18)F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.

Koopman D, van Dalen JA, Stigt JA, Slump CH, Knollema S, Jager PL.

Ann Nucl Med. 2016 Feb;30(2):145-52. doi: 10.1007/s12149-015-1041-z. Epub 2015 Dec 7.


Ultrasound-Guided Tissue Core Biopsies in Supraclavicular Lymph Nodes in Patients with Suspected Thoracic Malignancies.

Stigt JA, Boers JE, Boomsma MF.

Respiration. 2015;90(5):412-5. doi: 10.1159/000441301. Epub 2015 Oct 21.


Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer.

Mellema WW, Masen-Poos L, Smit EF, Hendriks LE, Aerts JG, Termeer A, Goosens MJ, Smit HJ, van den Heuvel MM, van der Wekken AJ, Herder GJ, Krouwels FH, Stigt JA, van den Borne BE, Haitjema TJ, Staal-Van den Brekel AJ, van Heemst RC, Pouw E, Dingemans AM.

Lung Cancer. 2015 Nov;90(2):249-54. doi: 10.1016/j.lungcan.2015.09.012. Epub 2015 Sep 15.


A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†.

Dingemans AM, Groen HJ, Herder GJ, Stigt JA, Smit EF, Bahce I, Burgers JA, van den Borne BE, Biesma B, Vincent A, van der Noort V, Aerts JG; NVALT study group.

Ann Oncol. 2015 Nov;26(11):2286-93. doi: 10.1093/annonc/mdv370. Epub 2015 Sep 7.


The Identification of Stenotrophomonas maltophilia Contamination in Ultrasound Endoscopes and Reproduction of Decontamination Failure by Deliberate Soiling Tests.

Stigt JA, Wolfhagen MJ, Smulders P, Lammers V.

Respiration. 2015;89(6):565-71. doi: 10.1159/000381725. Epub 2015 Apr 30.


Percutaneous ultrasonography as imaging modality and sampling guide for pulmonologists.

Stigt JA, Groen HJ.

Respiration. 2014;87(6):441-51. doi: 10.1159/000362930. Epub 2014 May 13. Review.


Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lung.

Stigt JA, 'tHart NA, Knol AJ, Uil SM, Groen HJ.

J Thorac Oncol. 2013 Aug;8(8):1012-8. doi: 10.1097/JTO.0b013e31829ce93e.


FDG uptake in the chest wall of a patient with small-cell lung cancer.

Stigt JA, Boomsma MF, van Bemmel BC.

J Thorac Oncol. 2013 Jun;8(6):806-7. doi: 10.1097/JTO.0b013e318287c544. No abstract available.


Esophageal fistula after EUS-FNA in a patient treated with bevacizumab for non-small-cell lung cancer.

Stigt JA, Boomsma MF, de Vos tot Nederveen Cappel WH.

J Thorac Oncol. 2013 Mar;8(3):e25-6. doi: 10.1097/JTO.0b013e318282e029. No abstract available.


A randomized controlled trial of postthoracotomy pulmonary rehabilitation in patients with resectable lung cancer.

Stigt JA, Uil SM, van Riesen SJ, Simons FJ, Denekamp M, Shahin GM, Groen HJ.

J Thorac Oncol. 2013 Feb;8(2):214-21. doi: 10.1097/JTO.0b013e318279d52a.


Diagnosing infectious spondylodiscitis with endoscopic ultrasound.

Stigt JA, Wolfhagen MJ, Boomsma MF, Mostert AK, Groen HJ.

J Bronchology Interv Pulmonol. 2012 Jan;19(1):82-4. doi: 10.1097/LBR.0b013e3182446924. No abstract available.


Analysis of "dry" mesothelioma with ultrasound guided biopsies.

Stigt JA, Boers JE, Groen HJ.

Lung Cancer. 2012 Dec;78(3):229-33. doi: 10.1016/j.lungcan.2012.09.004. Epub 2012 Sep 26.


A novel EGFR mutation in exon 19 showed stable disease after TKI treatment.

van der Wekken AJ, Stigt JA, A't Hart N.

J Thorac Oncol. 2012 Aug;7(8):e8. doi: 10.1097/JTO.0b013e31825ccae8. No abstract available.


A diagnostic program for patients suspected of having lung cancer.

Stigt JA, Uil SM, Oostdijk AH, Boers JE, van den Berg JW, Groen HJ.

Clin Lung Cancer. 2012 Nov;13(6):475-81. doi: 10.1016/j.cllc.2012.03.001. Epub 2012 Apr 11.


Percutaneous ultrasound-guided biopsies in the evaluation of thoracic tumours after PET-CT: a prospective diagnostic study.

Stigt JA, Oostdijk AH, Boers JE, van den Berg JW, Groen HJ.

Respiration. 2012;83(1):45-52. doi: 10.1159/000330018. Epub 2011 Sep 16.


Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062.

O'Brien ME, Konopa K, Lorigan P, Bosquee L, Marshall E, Bustin F, Margerit S, Fink C, Stigt JA, Dingemans AM, Hasan B, Van Meerbeeck J, Baas P.

Eur J Cancer. 2011 Oct;47(15):2322-30. doi: 10.1016/j.ejca.2011.05.020. Epub 2011 Jun 16.


Mediastinal incidentalomas.

Stigt JA, Boers JE, Oostdijk AH, van den Berg JW, Groen HJ.

J Thorac Oncol. 2011 Aug;6(8):1345-9. doi: 10.1097/JTO.0b013e31821d41c8.


Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.

Biesma B, Wymenga AN, Vincent A, Dalesio O, Smit HJ, Stigt JA, Smit EF, van Felius CL, van Putten JW, Slaets JP, Groen HJ; Dutch Chest Physician Study Group.

Ann Oncol. 2011 Jul;22(7):1520-7. doi: 10.1093/annonc/mdq637. Epub 2011 Jan 20.


Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.

Maas KW, El Sharouni SY, Phernambucq EC, Stigt JA, Groen HJ, Herder GJ, Van Den Borne BE, Senan S, Paul MA, Smit EF, Schramel FM.

Anticancer Res. 2010 Oct;30(10):4237-43.


Treatment of haemothorax.

Boersma WG, Stigt JA, Smit HJ.

Respir Med. 2010 Nov;104(11):1583-7. doi: 10.1016/j.rmed.2010.08.006. Review.


A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.

Senan S, Cardenal F, Vansteenkiste J, Stigt J, Akyol F, De Neve W, Bakker J, Dupont JM, Scagliotti GV, Ricardi U, van Meerbeeck JP.

Ann Oncol. 2011 Mar;22(3):553-8. doi: 10.1093/annonc/mdq388. Epub 2010 Aug 9.


Comparison of EUS-guided fine needle aspiration and integrated PET-CT in restaging after treatment for locally advanced non-small cell lung cancer.

Stigt JA, Oostdijk AH, Timmer PR, Shahin GM, Boers JE, Groen HJ.

Lung Cancer. 2009 Nov;66(2):198-204. doi: 10.1016/j.lungcan.2009.01.013. Epub 2009 Feb 20.


Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.

Pompen M, Gok M, Novák A, van Wuijtswinkel R, Biesma B, Schramel F, Stigt J, Smit H, Postmus P.

Lung Cancer. 2009 Apr;64(1):110-6. doi: 10.1016/j.lungcan.2008.07.009. Epub 2008 Sep 21.


A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatment.

Wachters FM, Groen HJ, Biesma B, Schramel FM, Postmus PE, Stigt JA, Smit EF.

Br J Cancer. 2005 Jan 17;92(1):15-20.


Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

O'Brien ME, Splinter T, Smit EF, Biesma B, Krzakowski M, Tjan-Heijnen VC, Van Bochove A, Stigt J, Smid-Geirnaerdt MJ, Debruyne C, Legrand C, Giaccone G; EORTC Lung Cancer Group.

Eur J Cancer. 2003 Jul;39(10):1416-22.


Thyroid carcinoma as first manifestation of familial adenomatous polyposis.

Stigt JA, Vasen HF, van der Linde K, van Vliet AC.

Neth J Med. 1996 Sep;49(3):116-8. Review.


Pulmonary function in Parkinson's disease.

Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meché FG, Stigt J.

J Neurol Neurosurg Psychiatry. 1989 Mar;52(3):329-33.


Maximal expiratory and inspiratory flow-volume curves in Parkinson's disease.

Bogaard JM, Hovestadt A, Meerwaldt J, vd Meché FG, Stigt J.

Am Rev Respir Dis. 1989 Mar;139(3):610-4.


Supplemental Content

Support Center